BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
14.05 USD  +0.14 (+1.01%)
Streaming Delayed Price  /  Updated: 12:19 PM EDT, Apr 16, 2014  /  Add to My Watchlist      
(KERX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 16, 2014
In the continuously up-and-down moving stock market, most investors may tend to shy away from the word "aggressive" in any sense - especially as it relates to investing their funds. Yet,...(read more)
Dmitry Balyasny is the founder of Balyasny Asset Management. He started his trading career at Schonfeld Securities in 1994. Balyasny’s Atlas Global fund returned 20+% average annual returns since its inception in 2002. The multistrategy hedge fund f...
(Penny Stock DD, 11/30/10)
 Keryx Biopharmaceuticals, Inc. (KERX: News ) Tuesday stated that its late-stage short-term efficacy study component of the Phase 3 registration program for...(read more)
Keryx Biopharmaceuticals (KERX) Company Overview

There is no analysis for KERX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here